A leading solution in target deconvolution and receptor identification
Retrogenix provides the leading solution for receptor and membrane target deconvolution. We specialise in discovering which human plasma membrane proteins are targeted by antibodies, proteins, small molecules and viruses.
Retrogenix identifies on behalf of its clients:
Target deconvolution is achieved by screening our clients’ molecules for interactions against the most comprehensive set of human plasma membrane proteins available in the context of the human cell. Now covering more than 3500 proteins, this represents the majority of known plasma membrane proteins.
Retrogenix has a rich client portfolio, including many global pharmaceutical / drug discovery companies and several notable academic institutions. We give our commercial clients a competitive advantage by identifying high quality, unexploited drug targets, and helping them to improve success rates at all stages of the drug research and development process.
27/10/2014 | Retrogenix expands science team. As a result of growing demand for Retrogenix’s services and ongoing investment in its research and development, Retrogenix is expanding rapidly and has recently welcomed two new scientists to the team... | Read More
Retrogenix will be attending the European Antibody Congress from the 10th - 12th November in Geneva, Switzerland | Find out more
“…"no doubt" that the breakthrough in identifying EPCR was due to the Retrogenix screening tool” | Read more
Professor Thomas Lavstsen, University of Copenhagen